Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.

Saved in:
Bibliographic Details
Title: Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.
Authors: Koch MW; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Camara-Lemarroy C; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada., Strijbis E; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands., Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands., Leavitt VM; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA., Repovic P; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA., Bowen JD; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA., Comtois J; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada., Uitdehaag B; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands., Cutter G; Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL, USA.
Source: Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2024 Dec; Vol. 30 (5_suppl), pp. 41-47. Date of Electronic Publication: 2024 Sep 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39245930
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koch+MW%22">Koch MW</searchLink>; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Camara-Lemarroy+C%22">Camara-Lemarroy C</searchLink>; Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Strijbis+E%22">Strijbis E</searchLink>; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mostert+J%22">Mostert J</searchLink>; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Leavitt+VM%22">Leavitt VM</searchLink>; Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Repovic+P%22">Repovic P</searchLink>; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Bowen+JD%22">Bowen JD</searchLink>; Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Comtois+J%22">Comtois J</searchLink>; Department of Medicine, Neurology Service, Hôpital de la Cité-de-la-Santé, Laval, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Uitdehaag+B%22">Uitdehaag B</searchLink>; Department of Neurology, MS Center Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Cutter+G%22">Cutter G</searchLink>; Department of Biostatistics, The University of Alabama at Birmingham, Birmingham, AL, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229509185%22">Multiple sclerosis (Houndmills, Basingstoke, England)</searchLink> [Mult Scler] 2024 Dec; Vol. 30 (5_suppl), pp. 41-47. <i>Date of Electronic Publication: </i>2024 Sep 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9509185 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-0970 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213524585%22">13524585 </searchLink><i>NLM ISO Abbreviation: </i>Mult Scler <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39245930
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/13524585241274620
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 41
    Titles:
      – TitleFull: Selecting Informative Patients for Phase 2 Progressive Trials in MS: Design Considerations for Phase 2 Clinical Trials in Progressive MS.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koch MW
      – PersonEntity:
          Name:
            NameFull: Camara-Lemarroy C
      – PersonEntity:
          Name:
            NameFull: Strijbis E
      – PersonEntity:
          Name:
            NameFull: Mostert J
      – PersonEntity:
          Name:
            NameFull: Leavitt VM
      – PersonEntity:
          Name:
            NameFull: Repovic P
      – PersonEntity:
          Name:
            NameFull: Bowen JD
      – PersonEntity:
          Name:
            NameFull: Comtois J
      – PersonEntity:
          Name:
            NameFull: Uitdehaag B
      – PersonEntity:
          Name:
            NameFull: Cutter G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2024 Dec
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1477-0970
          Numbering:
            – Type: volume
              Value: 30
            – Type: issue
              Value: 5_suppl
          Titles:
            – TitleFull: Multiple sclerosis (Houndmills, Basingstoke, England)
              Type: main
ResultId 1